196 related articles for article (PubMed ID: 37511120)
1. A Newly Established Cuproptosis-Related Gene Signature for Predicting Prognosis and Immune Infiltration in Uveal Melanoma.
Huang W; Yang F; Zhang Y; Fang Q; Lai Y; Lan Y
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511120
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel immune-related gene signature for prognosis and the tumor microenvironment in patients with uveal melanoma combining single-cell and bulk sequencing data.
Wang W; Zhao H; Wang S
Front Immunol; 2023; 14():1099071. PubMed ID: 36793711
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma.
Chen Y; Tang L; Huang W; Zhang Y; Abisola FH; Li L
Front Endocrinol (Lausanne); 2022; 13():963220. PubMed ID: 36353226
[TBL] [Abstract][Full Text] [Related]
4. Programmed Cell Death-Related Gene Signature Associated with Prognosis and Immune Infiltration and the Roles of HMOX1 in the Proliferation and Apoptosis were Investigated in Uveal Melanoma.
Zhao Y; Wang L; Li X; Jiang J; Ma Y; Guo S; Zhou J; Li Y
Genes Genomics; 2024 May; ():. PubMed ID: 38767825
[TBL] [Abstract][Full Text] [Related]
5. Identification of a prognostic model using cuproptosis-related genes in uveal melanoma.
Chen Y; Chen X; Wang X
Front Cell Dev Biol; 2022; 10():973073. PubMed ID: 36111345
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas.
Bao JH; Lu WC; Duan H; Ye YQ; Li JB; Liao WT; Li YC; Sun YP
Front Immunol; 2022; 13():933973. PubMed ID: 36045691
[TBL] [Abstract][Full Text] [Related]
7. Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma.
Peng X; Zhu J; Liu S; Luo C; Wu X; Liu Z; Li Y; Yuan R
Front Immunol; 2022; 13():990790. PubMed ID: 36248822
[TBL] [Abstract][Full Text] [Related]
8. Single cell sequencing analysis constructed the N7-methylguanosine (m7G)-related prognostic signature in uveal melanoma.
Xie J; Chen L; Cao Y; Ma C; Zhao W; Li J; Yao W; Hu Y; Wang M; Shi J
Aging (Albany NY); 2023 Mar; 15(6):2082-2096. PubMed ID: 36920166
[TBL] [Abstract][Full Text] [Related]
9. A Novel Glycolysis-Related Signature for Predicting the Prognosis and Immune Infiltration of Uveal Melanoma.
Guo X; Yu X; Zhang Y; Luo H; Huang R; Zeng Y; Duan C; Chen C
Ophthalmic Res; 2023; 66(1):692-705. PubMed ID: 36858025
[TBL] [Abstract][Full Text] [Related]
10. Identification of a prognostic cuproptosis-related signature in hepatocellular carcinoma.
Chen Y; Tang L; Huang W; Abisola FH; Zhang Y; Zhang G; Yao L
Biol Direct; 2023 Feb; 18(1):4. PubMed ID: 36750831
[TBL] [Abstract][Full Text] [Related]
11. Relationships of Cuproptosis-Related Genes With Clinical Outcomes and the Tumour Immune Microenvironment in Hepatocellular Carcinoma.
Chen X; Hu G; Xiong L; Xu Q
Pathol Oncol Res; 2022; 28():1610558. PubMed ID: 36213162
[No Abstract] [Full Text] [Related]
12. Identification and validation of a costimulatory molecule-related signature to predict the prognosis for uveal melanoma patients.
Zhao M; Yu Y; Song Z
Sci Rep; 2024 Apr; 14(1):9146. PubMed ID: 38644411
[TBL] [Abstract][Full Text] [Related]
13. Construction of oxidative phosphorylation-related prognostic risk score model in uveal melanoma.
Zhan Z; Lin K; Wang T
BMC Ophthalmol; 2024 May; 24(1):204. PubMed ID: 38698303
[TBL] [Abstract][Full Text] [Related]
14. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.
Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C
J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of cuproptosis-related prognostic gene signature and tumor immune microenvironment in HCC.
Qin H; Sheng W; Zhang G; Yang Q; Yao S; Yue Y; Zhang P; Zhu Y; Wang Q; Chen Y; Zeng H; Weng J; Yu F; Yang J
Front Genet; 2023; 14():1094793. PubMed ID: 36891150
[No Abstract] [Full Text] [Related]
16. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
17. A novel cuproptosis-related gene signature predicting overall survival in pediatric neuroblastoma patients.
Yang H; Yang J; Bian H; Wang X
Front Pediatr; 2022; 10():1049858. PubMed ID: 36568423
[TBL] [Abstract][Full Text] [Related]
18. Validation of an Ultraviolet Light Response Gene Signature for Predicting Prognosis in Patients with Uveal Melanoma.
Orozco CA; Mejía-García A; Ramírez M; González J; Castro-Vega L; Kreider RB; Serrano S; Combita AL; Bonilla DA
Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509183
[TBL] [Abstract][Full Text] [Related]
19. Cross talk between tumor stemness and microenvironment for prognosis and immunotherapy of uveal melanoma.
Wan Q; Ren X; Tang J; Ma K; Deng YP
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11951-11968. PubMed ID: 37420017
[TBL] [Abstract][Full Text] [Related]
20. A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma.
Bian Z; Fan R; Xie L
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]